Biomarker-s of Abusive Head Trauma by Proteomics

The aim of our study is to highlight biomarker-s of Abusive Head Trauma by proteomics analyses on the serum of child victims of abuse.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Abuse, Child Blood Protein Disorders Hematologic Diseases Hemic and Lymphatic Diseases Protein Disorder, Blood

Age range

Up to 2 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ginhoux Thiphanie, Lyon, Rhône, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age : 0-2 y.o
Medical consultation for malaise, seizure (without fever), loss of consciousness, traumatic bain injury, or cranioplasty
Blood test during medical care
Accepted informed consent

Exclusion criteria

Refused informed consent
For control groups : medical history of child abuse
For AHT group : rare metabolic disease (Menkes, etc..)

Treatment and study plan

Blood Test

Other

Proteomic analyses on serum

Primary outcomes

Highlight novel biomarker-s of AHT

Time frame: Hospital admission to discharge (up to 3 days)

Proteomic analyses will be made on serum of infant victim of AHT. Results will be compare with control groups (traumatic brain injury, cranioplasty, malaise).

Study contacts

Contact information is provided by the study sponsor or research team.

Kim Wiskott, MD

CONTACT

[email protected]

0041797737424

Sponsors and collaborators

Lead sponsor

University Hospital, Geneva

Other

Collaborators

Hospices Civils de Lyon

Registry information

Official study title

Identification of Novel Biomarker-s of Abusive Head Trauma on Serum by Proteomics

Important dates

Study start: 2023
Primary completion: 2028
Study completion: 2028
First posted: Nov 23, 2022
Registry last updated: Jan 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Enrolling by Invitation